Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer

Mieke Van Hemelrijck1, Hans Garmo2, Lars Lindhagen3

  • 1Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK; Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.

European Urology
|November 7, 2016
PubMed
Abstract

Related Concept Videos